These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 12691730

  • 1. Streptozotocin-induced diabetic mice are resistant to lethal effects of thioacetamide hepatotoxicity.
    Shankar K, Vaidya VS, Wang T, Bucci TJ, Mehendale HM.
    Toxicol Appl Pharmacol; 2003 Apr 15; 188(2):122-34. PubMed ID: 12691730
    [Abstract] [Full Text] [Related]

  • 2. Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats.
    Wang T, Fontenot RD, Soni MG, Bucci TJ, Mehendale HM.
    Toxicol Appl Pharmacol; 2000 Jul 15; 166(2):92-100. PubMed ID: 10896850
    [Abstract] [Full Text] [Related]

  • 3. Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity.
    Sawant SP, Dnyanmote AV, Warbritton A, Latendresse JR, Mehendale HM.
    Toxicol Appl Pharmacol; 2006 Mar 15; 211(3):221-32. PubMed ID: 16153671
    [Abstract] [Full Text] [Related]

  • 4. Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality.
    Wang T, Shankar K, Bucci TJ, Warbritton A, Mehendale HM.
    Toxicol Appl Pharmacol; 2001 May 15; 173(1):27-37. PubMed ID: 11350212
    [Abstract] [Full Text] [Related]

  • 5. Diet restriction enhances compensatory liver tissue repair and survival following administration of lethal dose of thioacetamide.
    Ramaiah SK, Soni MG, Bucci TJ, Mehendale HM.
    Toxicol Appl Pharmacol; 1998 May 15; 150(1):12-21. PubMed ID: 9630448
    [Abstract] [Full Text] [Related]

  • 6. Type 1 diabetic mice are protected from acetaminophen hepatotoxicity.
    Shankar K, Vaidya VS, Apte UM, Manautou JE, Ronis MJ, Bucci TJ, Mehendale HM.
    Toxicol Sci; 2003 Jun 15; 73(2):220-34. PubMed ID: 12700423
    [Abstract] [Full Text] [Related]

  • 7. Prior administration of a low dose of thioacetamide protects type 1 diabetic rats from subsequent administration of lethal dose of thioacetamide.
    Devi SS, Philip BK, Warbritton A, Latendresse JR, Mehendale HM.
    Toxicology; 2006 Sep 21; 226(2-3):107-17. PubMed ID: 16901604
    [Abstract] [Full Text] [Related]

  • 8. Temporal changes in tissue repair permit survival of diet-restricted rats from an acute lethal dose of thioacetamide.
    Ramaiah SK, Bucci TJ, Warbritton A, Soni MG, Mehendale HM.
    Toxicol Sci; 1998 Oct 21; 45(2):233-41. PubMed ID: 9848130
    [Abstract] [Full Text] [Related]

  • 9. Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity.
    Mangipudy RS, Rao PS, Mehendale HM.
    Environ Health Perspect; 1996 Jul 21; 104(7):744-9. PubMed ID: 8841760
    [Abstract] [Full Text] [Related]

  • 10. Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality.
    Chanda S, Mangipudy RS, Warbritton A, Bucci TJ, Mehendale HM.
    Hepatology; 1995 Feb 21; 21(2):477-86. PubMed ID: 7843722
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of type 2 diabetes on acetaminophen-induced hepatotoxicity in male Swiss-Webster mice.
    Sawant SP, Dnyanmote AV, Mitra MS, Chilakapati J, Warbritton A, Latendresse JR, Mehendale HM.
    J Pharmacol Exp Ther; 2006 Feb 21; 316(2):507-19. PubMed ID: 16207833
    [Abstract] [Full Text] [Related]

  • 12. Diabetic mice are protected from normally lethal nephrotoxicity of S-1,2-dichlorovinyl-L-cysteine (DCVC): role of nephrogenic tissue repair.
    Dnyanmote AV, Sawant SP, Lock EA, Latendresse JR, Warbritton AA, Mehendale HM.
    Toxicol Appl Pharmacol; 2006 Mar 01; 211(2):133-47. PubMed ID: 16125744
    [Abstract] [Full Text] [Related]

  • 13. Role of CYP2E1 and saturation kinetics in the bioactivation of thioacetamide: Effects of diet restriction and phenobarbital.
    Chilakapati J, Korrapati MC, Shankar K, Hill RA, Warbritton A, Latendresse JR, Mehendale HM.
    Toxicol Appl Pharmacol; 2007 Feb 15; 219(1):72-84. PubMed ID: 17234228
    [Abstract] [Full Text] [Related]

  • 14. Disrupted G1 to S phase clearance via cyclin signaling impairs liver tissue repair in thioacetamide-treated type 1 diabetic rats.
    Devi SS, Mehendale HM.
    Toxicol Appl Pharmacol; 2005 Sep 01; 207(2):89-102. PubMed ID: 15953624
    [Abstract] [Full Text] [Related]

  • 15. Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats.
    Ramaiah SK, Apte U, Mehendale HM.
    Drug Metab Dispos; 2001 Aug 01; 29(8):1088-95. PubMed ID: 11454726
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of inhibited liver tissue repair in toxicant challenged type 2 diabetic rats.
    Sawant SP, Dnyanmote AV, Mehendale HM.
    Toxicology; 2007 Apr 11; 232(3):200-15. PubMed ID: 17298859
    [Abstract] [Full Text] [Related]

  • 17. Genetically obese (ob/ob) mice are resistant to the lethal effects of thioacetamide hepatotoxicity.
    Won YS, Song JW, Lim JH, Lee MY, Moon OS, Kim HC, Son HY, Kwon HJ.
    Toxicol Appl Pharmacol; 2016 Jan 15; 291():38-45. PubMed ID: 26701066
    [Abstract] [Full Text] [Related]

  • 18. Microarray analysis of thioacetamide-treated type 1 diabetic rats.
    Devi SS, Mehendale HM.
    Toxicol Appl Pharmacol; 2006 Apr 01; 212(1):69-78. PubMed ID: 16297948
    [Abstract] [Full Text] [Related]

  • 19. Temporal changes in tissue repair upon repeated exposure to thioacetamide.
    Mangipudy RS, Mehendale HM.
    Toxicol Appl Pharmacol; 1998 Apr 01; 149(2):254-7. PubMed ID: 9571995
    [Abstract] [Full Text] [Related]

  • 20. Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1.
    Wang T, Shankar K, Ronis MJ, Mehendale HM.
    J Pharmacol Exp Ther; 2000 Aug 01; 294(2):473-9. PubMed ID: 10900221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.